Co-Authors
This is a "connection" page, showing publications co-authored by Kar-Ming Fung and Megan Lerner.
Connection Strength
0.313
-
A tale of two multi-focal therapies for glioblastoma: An antibody targeting ELTD1 and nitrone-based OKN-007. J Cell Mol Med. 2022 01; 26(2):570-582.
Score: 0.050
-
ELTD1 as a multi-focal target for malignant gliomas: preclinical studies. Neurooncol Adv. 2021 Jan-Dec; 3(1):vdab132.
Score: 0.050
-
OKlahoma Nitrone-007: novel treatment for diffuse intrinsic pontine glioma. J Transl Med. 2020 11 10; 18(1):424.
Score: 0.047
-
Assessment of an scFv Antibody Fragment Against ELTD1 in a G55 Glioblastoma Xenograft Model. Transl Oncol. 2020 Mar; 13(3):100737.
Score: 0.045
-
Optimized monoclonal antibody treatment against ELTD1 for GBM in a G55 xenograft mouse model. J Cell Mol Med. 2020 01; 24(2):1738-1749.
Score: 0.044
-
Targeting ELTD1, an angiogenesis marker for glioblastoma (GBM), also affects VEGFR2: molecular-targeted MRI assessment. Am J Nucl Med Mol Imaging. 2019; 9(1):93-109.
Score: 0.041
-
ELTD1, an effective anti-angiogenic target for gliomas: preclinical assessment in mouse GL261 and human G55 xenograft glioma models. Neuro Oncol. 2017 02 01; 19(2):175-185.
Score: 0.036